Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,870 | 88,739 | 109,558 | 122,754 | 125,286 |
| Marketable Securities | 19,055 | 18,185 | 21,711 | 19,024 | 18,484 |
| Receivables | 60,589 | 40,401 | 51,557 | 21,793 | 12,492 |
| Other current assets | 0 | 1 | 0 | 0 | -1 |
| TOTAL | $157,514 | $147,326 | $182,826 | $163,571 | $156,261 |
| Non-Current Assets | |||||
| Investments And Advances | 39,025 | 37,001 | 37,041 | 47,180 | 48,294 |
| Other Non-Current Assets | 12,588 | 25,678 | 68,397 | 93,689 | 103,086 |
| TOTAL | $51,613 | $62,679 | $105,438 | $140,869 | $151,380 |
| Total Assets | $217,043 | $219,005 | $298,434 | $316,475 | $320,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,817 | 2,215 | 32,832 | 36,378 | 2,430 |
| Accounts payable and accrued liabilities | 20,708 | 22,032 | 19,865 | 33,805 | 20,515 |
| Other current liabilities | 14,547 | 19,307 | 25,587 | 24,330 | 28,407 |
| TOTAL | $41,072 | $43,554 | $78,284 | $94,513 | $51,352 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,516 | 42,301 | 13,327 | 15,975 | 17,453 |
| Other Non-Current Liabilities | 57,296 | 58,723 | 65,877 | 42,858 | 51,268 |
| TOTAL | $112,875 | $118,397 | $96,349 | $94,848 | $108,485 |
| Total Liabilities | $153,948 | $161,951 | $174,632 | $189,361 | $159,837 |
| Shareholders' Equity | |||||
| Common Shares | 4,391 | 4,226 | 4,244 | 4,706 | 4,762 |
| Retained earnings | -358,302 | -348,021 | -283,011 | -322,055 | -294,176 |
| Other shareholders' equity | 1,158 | 862 | 303 | 538 | 862 |
| TOTAL | $63,094 | $57,053 | $123,802 | $127,112 | $160,928 |
| Total Liabilities And Equity | $217,042 | $219,004 | $298,434 | $316,473 | $320,765 |